Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure · Other events
  3. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  4. 8-K Event Executive or director change
  5. 8-K Event Acquisition or sale completed · Executive or director change
  6. 8-K Event Delisting notice
  7. 8-K Event Executive or director change
  8. 8-K Event Other events
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 8-K Event Executive or director change
  12. 8-K/A Event Other events
  13. 8-K/A Event Shareholder rights changed
  14. 8-K Event Shareholder rights changed · Bylaws or fiscal year change
  15. 8-K Event Shareholder vote results
  16. 8-K Event Other events
  17. 8-K/A Event Regulation FD disclosure
  18. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  19. 10-Q Report Quarterly Report
  20. 8-K Event Other events

Page 1 of 6 · 114 filings